Darvon Recall and Darvocet Recall: Lawyers Reviewing Lawsuits
On Friday, the FDA finally decided to issue a Darvon recall and Darvocet recall after determining that all painkillers that contain propxyphene pose an unreasonable risk to consumers. The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Darvon lawsuits and Darvocet lawsuits for individuals who have experienced serious or fatal injuries as a result of these medications.
Darvon (propxyphene) was first introduced in 1957 as a mild pain reliever. Darvocet was introduced as a combination drug that contained both propxyphene and acetaminophen, the active ingredient in Tylenol. At the time of the recall, Darvocet was one of the most commonly prescribed medications in the United States.
Although experts have been indicating for years that a recall of Darvon and Darvocet should be issued, the medications were sold to millions of Americans without adequate warning about the risk of injury or death. Individuals may be entitled to compensation through a Darvon recall lawsuit or Darvocet recall lawsuit if they have suffered any of the following injuries:
- Heart Arrythmia
- Heart Attack
- Sudden Death
We first wrote about the potential risk of problems from Darvon and Darvocet side effects in June 2008, when the consumer watchdog group Public Citizen filed a lawsuit against the FDA as a result of their failure to act on a petition filed in 2006 to remove the painkillers from the market. Public Citizen requested that the dangerous painkillers be phased off of the market, citing more than 2,000 accidental deaths linked to the medications since 1981. In addition, it is a relatively weak painkiller that is no more effective than many over-the-counter painkillers.
In February 2009, we wrote about an FDA Advisory Panel meeting convened to review the risk of Darvon and Darvocet death. Although experts determined that the risks associated with side effects of Darvocet and Darvon outweigh the potential benefits, the FDA disregarded the recommendation of their advisory panel and decided not to issue a Darvon and Darvocet recall at that time.
Nearly two years later, on November 17, 2010, the FDA determined that new clinical data tipped the scales in favor of a recall, after finding that there is a risk of heart arrythmia from Darvocet and Darvon.
DARVON LAWYERS AND DARVOCET LAWYERS
Although it appears that the FDA failed to promptly protect consumers from these dangerous painkillers, ultimate responsibility falls on the drug makers, who placed their desire for profits ahead of consumer safety by continuing to sell the medications without adequate warnings about the Darvon and Darvocet risks.
To review a potential claim for yourself, a friend or family member with our Darvon and Darvocet lawyers, request a free consultation and claim evaluation.